Concurrent chemoradiotherapy as the most appropriate treatment for most T3 laryngeal carcinomas.
Enepekides
Danny J
DJ
Department of Otolaryngology-Head and Neck Surgery, UC Davis Medical Center, Sacramento, USA. danny.enepekides@ucdmc.ucdavis.edu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007822:Laryngeal Neoplasms / Q000628:therapy*; D007825:Laryngectomy / Q000379:methods; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant; D016879:Salvage Therapy; D016896:Treatment Outcome
D002945:Cisplatin; D005472:Fluorouracil